Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHB2100027	Lazertinib 片	lazertinib mesylate	Tablet	Chemical Drugs(2.4)	Supplementary Application	2021-03-11	强生（中国）投资有限公司	Johnson & Johnson (CHINA) Investment Ltd	In Review	2022-01-27	view
JXHL2000207	Lazertinib 片	lazertinib mesylate	Tablet	Chemical Drugs(1)	Import Drug Application	2020-07-10	强生（中国）投资有限公司	Johnson & Johnson (CHINA) Investment Ltd	In Review	2020-07-09	view
JXHL2000208	Lazertinib 片	lazertinib mesylate	Tablet	Chemical Drugs(1)	Import Drug Application	2020-07-10	强生（中国）投资有限公司	Johnson & Johnson (CHINA) Investment Ltd	In Review	2020-07-09	view
JXHL2000210	Lazertinib 片	lazertinib mesylate	Tablet	Chemical Drugs(1)	Import Drug Application	2020-07-10	强生（中国）投资有限公司	Johnson & Johnson (CHINA) Investment Ltd	In Review	2020-07-09	view